NCT00718120View on ClinicalTrials.gov

Immunogenicity and Safety Study of GSK Biologicals' Fluviral® (2008 - 2009 Season) in Adults Over 18 Years

PHASE3CompletedINTERVENTIONAL

Enrollment

110

Participants

Timeline

Start Date

July 18, 2008

Primary Completion Date

August 9, 2008

Study Completion Date

August 9, 2008

Conditions

Influenza Vaccines

Interventions

BIOLOGICAL

Fluviral®

One intramuscular injection into the deltoid region of the non-dominant arm

Trial Locations (1)

J1H 1Z1

GSK Investigational Site, Sherbrooke

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY

NCT00718120 - Immunogenicity and Safety Study of GSK Biologicals' Fluviral® (2008 - 2009 Season) in Adults Over 18 Years | Biotech Hunter | Biotech Hunter